DBV Technologies (DBVT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $692.19M
Last updated: Nov 17, 2026 at 11:03 AM ET
DBV Technologies (DBVT) Financials: Revenue, Profit and Cash Flow
DBV Technologies reported revenue of EUR 0 for the fiscal year ended Dec 31, 2025, down 100.0% from the year before. That year, net income was EUR -146.95M, operating cash flow was EUR -121.18M and free cash flow was EUR -121.71M. The quarter ended Sep 30, 2026 had revenue of EUR 0 and net income of EUR -64.50M.
Revenue and Margins
The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of EUR 147.06M.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | 0 | -100.0% | N/A | N/A | N/A |
| Dec 2024 | 2.57M | -83.7% | -265.3% | -4693.4% | -4428.2% |
| Dec 2023 | 15.73M | +224.7% | 100.0% | -486.0% | -462.4% |
| Dec 2022 | 4.84M | -15.1% | 100.0% | -1994.9% | -1987.5% |
| Dec 2021 | 5.71M | -49.4% | -82.0% | -1727.6% | -1713.5% |
| Dec 2020 | 11.28M | -23.3% | 100.0% | -1408.7% | -1415.0% |
| Dec 2019 | 14.71M | +14.8% | 100.0% | -1162.8% | -1169.5% |
| Dec 2018 | 12.81M | +11.3% | 100.0% | -1483.6% | -1484.7% |
| Dec 2017 | 11.52M | +45.3% | 100.0% | -1510.0% | -1538.3% |
| Dec 2016 | 7.93M | N/A | 100.0% | -1540.6% | -1593.9% |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 2.57M | 15.73M | 4.84M | 5.71M | 11.28M | 14.71M | 12.81M | 11.52M | 7.93M |
| Cost of revenue | 17.67M | 6.81M | -4.50M | 20.30M | 10.39M | 17.49M | 3.09M | 5.03M | 3.43M | 1.42M |
| Gross profit | -17.67M | -6.81M | 15.73M | 4.84M | -4.68M | 11.28M | 14.71M | 12.81M | 11.52M | 7.93M |
| Research and development | 116.68M | 89.90M | 60.22M | 75.54M | 70.34M | 101.61M | 112.24M | 123.50M | 126.25M | 82.90M |
| Operating income | -147.06M | -120.53M | -76.43M | -96.63M | -98.61M | -158.84M | -171.02M | -190.12M | -173.94M | -122.13M |
| Net income | -146.95M | -113.72M | -72.73M | -96.27M | -97.81M | -159.56M | -172.01M | -190.26M | -177.20M | -126.35M |
| EBITDA | -143.86M | -110.99M | -63.27M | -83.47M | -91.16M | -124.83M | -168.43M | -186.64M | -170.06M | -120.25M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 511.00K | 0 | 1.07M | 1.16M | 1.41M | 8.88M |
| Gross profit | N/A | N/A | -4.22M | -4.28M | -4.28M | -4.62M | 511.00K | N/A | 1.07M | -4.15M | 1.41M | 8.88M |
| Operating income | -64.80M | -51.30M | -47.90M | -45.05M | -36.89M | -43.11M | -26.62M | -23.86M | -30.33M | -34.97M | -28.56M | -11.92M |
| Net income | -64.50M | -50.40M | -47.60M | -44.83M | -33.02M | -42.40M | -27.08M | -23.02M | -30.44M | -33.09M | -27.34M | -11.19M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of EUR 16.27M by 177.89M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 233.72M | 65.66M | 182.99M | 246.52M | 146.32M | 272.25M | 271.73M | 234.76M | 250.28M | 317.16M |
| Current assets | 212.94M | 44.39M | 158.91M | 223.07M | 114.52M | 207.37M | 204.55M | 198.83M | 220.81M | 300.26M |
| Cash and equivalents | 194.17M | 32.46M | 141.37M | 209.19M | 77.30M | 196.35M | 193.25M | 167.81M | 194.08M | 282.93M |
| Total liabilities | 64.95M | 38.27M | 42.80M | 52.06M | 47.29M | 66.75M | 78.54M | 68.98M | 67.40M | 49.26M |
| Short-term debt | 16.27M | 1.50M | 2.03M | 8.90M | 3.51M | 4.43M | 4.33M | N/A | N/A | N/A |
| Long-term debt | N/A | N/A | N/A | N/A | N/A | 543.00K | 721.00K | 1.28M | 1.82M | 4.05M |
| Shareholder equity | 168.77M | 27.39M | 140.19M | 194.45M | 99.03M | 205.49M | 193.19M | 165.78M | 182.88M | 267.90M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 215.40M | 223.20M | 266.40M | 233.72M | 110.50M | 143.43M | 50.56M | 65.66M | 93.06M | 114.19M | 145.90M | 182.99M |
| Total liabilities | 66.70M | 62.80M | 58.50M | 64.95M | 57.64M | 57.20M | 47.69M | 38.27M | 39.02M | 35.09M | 34.24M | 42.80M |
| Cash and equivalents | 165.70M | 174.90M | 229.20M | 194.17M | 69.84M | 103.21M | 12.96M | 32.46M | 46.44M | 66.21M | 101.53M | 141.37M |
| Shareholder equity | 148.60M | 160.40M | 207.90M | 168.77M | 52.85M | 86.22M | 2.87M | 27.39M | 54.03M | 79.09M | 111.65M | 140.19M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -121.18M | -104.47M | -79.65M | -55.70M | -108.24M | -165.61M | -148.35M | -186.74M | -160.91M | -65.68M |
| Capital expenditures | 533.64K | 2.34M | 677.00K | 754.00K | 918.00K | 2.76M | 5.60M | N/A | 10.62M | N/A |
| Free cash flow | -121.71M | -106.81M | -80.33M | -56.45M | -109.16M | -168.37M | -153.94M | N/A | -171.53M | N/A |
| Dividends paid | N/A | N/A | N/A | N/A | N/A | 303.00K | 0 | 0 | 0 | 0 |
| Investing cash flow | -1.37M | -757.00K | -808.00K | -100.00K | -433.00K | -2.87M | -5.66M | -11.81M | -11.03M | N/A |
| Financing cash flow | 276.18M | 587.00K | 6.77M | 194.10M | 274.00K | 149.55M | 207.58M | 178.62M | N/A | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -51.50M | -83.08M | -49.10M | -35.17M | -32.44M | -33.91M | -19.67M | -12.25M | -22.46M | -35.07M | -34.69M | -13.69M |
| Capital expenditures | 42.00K | 10.00K | 400.00K | 373.00K | 117.00K | 32.00K | 10.00K | 125.00K | 396.00K | 732.00K | 1.33M | 352.00K |
| Free cash flow | -51.54M | -83.09M | -49.50M | -35.55M | -32.55M | -33.94M | -19.68M | -12.38M | -22.85M | -35.80M | -36.03M | -14.04M |
Frequently Asked Questions About DBVT
What is DBV Technologies' annual revenue?
DBV Technologies reported revenue of EUR 0 for the fiscal year ended Dec 31, 2025.
How fast is DBV Technologies' revenue growing?
Revenue was down 100.0% for the fiscal year ended Dec 31, 2025 compared with the year before.
Is DBV Technologies profitable?
No. DBV Technologies reported net income of EUR -146.95M for the fiscal year ended Dec 31, 2025.
How much free cash flow does DBVT generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of EUR -121.18M minus capital expenditures of EUR 533.64K produced free cash flow of EUR -121.71M.
How much debt does DBV Technologies have?
The balance sheet dated Dec 31, 2025 reported short-term debt of EUR 16.27M and cash and equivalents of EUR 194.17M.
DBVT pages: Overview, Financials, Competitors